Agonist efficacy and receptor desensitization: from partial truths to a fuller picture.

作者: Steven J Charlton

DOI: 10.1111/J.1476-5381.2009.00352.X

关键词:

摘要: It has been demonstrated that the degree of agonist-induced desensitization β2-adrenoceptor is related to agonist efficacy (strength signalling), whereby high-efficacy agonists (e.g. formoterol) cause more phosphorylation and internalization receptor than low-efficacy salmeterol). These early studies, however, used a protocol where were matched for occupancy rather functional effect. In this issue BJP, Duringer colleagues have extended these studies compare ability at equi-effective (cAMP signalling) concentrations equal occupancy. Their data conclusions are quite different from those previously described. After prolonged exposure, all caused similar desensitization, whereas pulse uncovered greater loss responsiveness with ligands. This consistent notion ‘spare receptors’, therefore less sensitive receptors through desensitization. also reflects experience in clinic, both formoterol salmeterol show decline bronchoprotection, after which their effects remain stable. findings challenge ligands always

参考文章(38)
A J Knox, K Mortimer, Combining inhaled glucocorticoids and long acting β2-adrenoceptor agonists in asthma and COPD British Journal of Pharmacology. ,vol. 153, pp. 1085- 1086 ,(2009) , 10.1038/BJP.2008.4
H Booth, R Bish, J Walters, F Whitehead, E H Walters, Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax. ,vol. 51, pp. 1100- 1104 ,(1996) , 10.1136/THX.51.11.1100
E BLEECKER, S YANCEY, L BAITINGER, L EDWARDS, M KLOTSMAN, W ANDERSON, P DORINSKY, Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma The Journal of Allergy and Clinical Immunology. ,vol. 118, pp. 809- 816 ,(2006) , 10.1016/J.JACI.2006.06.036
Brian Lipworth, Soong Tan ChB, Martin Devlin, Trevor Aiken ChB, Rachel Baker, David Hendrick, Effects of Treatment with Formoterol on Bronchoprotection against Methacholine The American Journal of Medicine. ,vol. 104, pp. 431- 438 ,(1998) , 10.1016/S0002-9343(98)00086-2
M JOHNSON, Molecular mechanisms of β2-adrenergic receptor function, response, and regulation The Journal of Allergy and Clinical Immunology. ,vol. 117, pp. 18- 24 ,(2006) , 10.1016/J.JACI.2005.11.012
Caroline Düringer, Gunilla Grundström, Eylem Gürcan, Ian A Dainty, Mandy Lawson, Solange H Korn, Anders Jerre, Hanna Falk Håkansson, Elisabet Wieslander, Karin Fredriksson, Carl Magnus Sköld, Magnus Löfdahl, Claes-Göran Löfdahl, David J Nicholls, David S Silberstein, Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure. British Journal of Pharmacology. ,vol. 158, pp. 169- 179 ,(2009) , 10.1111/J.1476-5381.2009.00262.X
Richard B. Clark, Brian J. Knoll, Roger Barber, Partial agonists and G protein-coupled receptor desensitization Trends in Pharmacological Sciences. ,vol. 20, pp. 279- 286 ,(1999) , 10.1016/S0165-6147(99)01351-6
Robert H. Moore, Ellen E. Millman, Veronica Godines, Nicola A. Hanania, Tuan M. Tran, Hui Peng, Burton F. Dickey, Brian J. Knoll, Richard B. Clark, Salmeterol Stimulation Dissociates β2-Adrenergic Receptor Phosphorylation and Internalization American Journal of Respiratory Cell and Molecular Biology. ,vol. 36, pp. 254- 261 ,(2007) , 10.1165/RCMB.2006-0158OC